274 related articles for article (PubMed ID: 30716324)
1. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.
Skaro M; Nanda N; Gauthier C; Felsenstein M; Jiang Z; Qiu M; Shindo K; Yu J; Hutchings D; Javed AA; Beckman R; He J; Wolfgang CL; Thompson E; Hruban RH; Klein AP; Goggins M; Wood LD; Roberts NJ
Gastroenterology; 2019 May; 156(6):1905-1913. PubMed ID: 30716324
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
[TBL] [Abstract][Full Text] [Related]
3. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.
Fischer CG; Beleva Guthrie V; Braxton AM; Zheng L; Wang P; Song Q; Griffin JF; Chianchiano PE; Hosoda W; Niknafs N; Springer S; Dal Molin M; Masica D; Scharpf RB; Thompson ED; He J; Wolfgang CL; Hruban RH; Roberts NJ; Lennon AM; Jiao Y; Karchin R; Wood LD
Gastroenterology; 2019 Oct; 157(4):1123-1137.e22. PubMed ID: 31175866
[TBL] [Abstract][Full Text] [Related]
4. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
5. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
Matthaei H; Norris AL; Tsiatis AC; Olino K; Hong SM; dal Molin M; Goggins MG; Canto M; Horton KM; Jackson KD; Capelli P; Zamboni G; Bortesi L; Furukawa T; Egawa S; Ishida M; Ottomo S; Unno M; Motoi F; Wolfgang CL; Edil BH; Cameron JL; Eshleman JR; Schulick RD; Maitra A; Hruban RH
Ann Surg; 2012 Feb; 255(2):326-33. PubMed ID: 22167000
[TBL] [Abstract][Full Text] [Related]
7. Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk.
Overbeek KA; Koopmann BDM; Levink IJM; Tacelli M; Erler NS; Arcidiacono PG; Ausems MGE; Wagner A; van Eijck CH; Groot Koerkamp B; Busch OR; Besselink MG; van der Vlugt M; van Driel LMJW; Fockens P; Vleggaar FP; Poley JW; Capurso G; Cahen DL; Bruno MJ;
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):62-71.e7. PubMed ID: 37031711
[TBL] [Abstract][Full Text] [Related]
8. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
[TBL] [Abstract][Full Text] [Related]
9. Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Tomosugi T; Kimura R; Nakamura S; Miyasaka Y; Nakata K; Mori Y; Morita M; Torata N; Shindo K; Ohuchida K; Nakamura M
Surg Today; 2019 Nov; 49(11):887-893. PubMed ID: 30879148
[TBL] [Abstract][Full Text] [Related]
10. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M
Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484
[TBL] [Abstract][Full Text] [Related]
11. Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.
Hutchings D; Jiang Z; Skaro M; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Zheng L; Klimstra DS; Brand RE; Singhi AD; Goggins M; Klein AP; Roberts NJ; Hruban RH
Mod Pathol; 2019 Dec; 32(12):1806-1813. PubMed ID: 31285527
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
[TBL] [Abstract][Full Text] [Related]
13. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic
Fujikura K; Hosoda W; Felsenstein M; Song Q; Reiter JG; Zheng L; Beleva Guthrie V; Rincon N; Dal Molin M; Dudley J; Cohen JD; Wang P; Fischer CG; Braxton AM; Noë M; Jongepier M; Fernández-Del Castillo C; Mino-Kenudson M; Schmidt CM; Yip-Schneider MT; Lawlor RT; Salvia R; Roberts NJ; Thompson ED; Karchin R; Lennon AM; Jiao Y; Wood LD
Gut; 2021 May; 70(5):928-939. PubMed ID: 33028669
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
16. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Molin MD; Matthaei H; Wu J; Blackford A; Debeljak M; Rezaee N; Wolfgang CL; Butturini G; Salvia R; Bassi C; Goggins MG; Kinzler KW; Vogelstein B; Eshleman JR; Hruban RH; Maitra A
Ann Surg Oncol; 2013 Nov; 20(12):3802-8. PubMed ID: 23846778
[TBL] [Abstract][Full Text] [Related]
18. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
Roch AM; Kim RC; Nguyen TK; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
J Surg Oncol; 2023 Aug; 128(2):289-294. PubMed ID: 37083062
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract][Full Text] [Related]
20. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
